Crystal Structure of the Bovine Lactadherin C2 Domain, a Membrane Binding Motif, Shows Similarity to the C2 Domains of Factor V and Factor VIII

Journal of Molecular Biology

Volumn 371, Issue 3, 2007, Pages 717-724

  Lin, Lin ^a   Huai, Qing ^a   Huang, Mingdong ^a   Furie, Bruce ^a   Furie, Barbara C ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

C2 domain; crystal structure; factor V; factor VIII; lactadherin

Indexed keywords

BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; DISCOIDIN; DISULFIDE; LACTADHERIN; PHOSPHATIDYLSERINE;

AMINO TERMINAL SEQUENCE; ARTICLE; BETA SHEET; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CELL SURFACE; CRYSTAL STRUCTURE; HYDROPHOBICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN MOTIF; PROTEIN STRUCTURE; SEQUENCE HOMOLOGY; X RAY CRYSTALLOGRAPHY;

BOVINAE;

EID: 34447649216     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2007.05.054     Document Type: Article

References (54)

1. Butler J.E., Pringnitz D.J., Martens C.L., and Crouch N. Bovine-associated mucoprotein: I. Distribution among adult and fetal bovine tissues and body fluids. Differentiation 17 (1980) 31-40
2. Ensslin M., Calvete J.J., Thole H.H., Sierralta W.D., Adermann K., Sanz L., and Topfer-Petersen E. Identification by affinity chromatography of boar sperm membrane-associated proteins bound to immobilized porcine zona pellucida. Mapping of the phosphorylethanolamine-binding region of spermadhesin AWN. Biol. Chem. Hoppe Seyler 376 (1995) 733-738
3. Silvestre J.S., Thery C., Hamard G., Boddaert J., Aguilar B., Delcayre A., et al. Lactadherin promotes VEGF-dependent neovascularization. Nature Med. 11 (2005) 499-506
4. Hanayama R., Tanaka M., Miwa K., Shinohara A., Iwamatsu A., and Nagata S. Identification of a factor that links apoptotic cells to phagocytes. Nature 417 (2002) 182-187
5. Stubbs J.D., Lekutis C., Singer K.L., Bui A., Yuzuki D., Srinivasan U., and Parry G. cDNA cloning of a mouse mammary epithelial cell surface protein reveals the existence of epidermal growth factor-like domains linked to factor VIII-like sequences. Proc. Natl Acad. Sci. USA 87 (1990) 8417-8421
6. Andersen M.H., Graversen H., Fedosov S.N., Petersen T.E., and Rasmussen J.T. Functional analyses of two cellular binding domains of bovine lactadherin. Biochemistry 39 (2000) 6200-6206
7. Wu Y., Tibrewal N., and Birge R.B. Phosphatidylserine recognition by phagocytes: a view to a kill. Trends Cell Biol. 16 (2006) 189-197
8. Hanayama R., and Nagata S. Impaired involution of mammary glands in the absence of milk fat globule EGF factor 8. Proc. Natl Acad. Sci. USA 102 (2005) 16886-16891
9. Hanayama R., Miyasaka K., Nakaya M., and Nagata S. MFG-E8-dependent clearance of apoptotic cells, and autoimmunity caused by its failure. Curr. Dir. Autoimmun. 9 (2006) 162-172
10. Ortel T.L., Devore-Carter D., Quinn-Allen M., and Kane W.H. Deletion analysis of recombinant human factor V. Evidence for a phosphatidylserine binding site in the second C-type domain. J. Biol. Chem. 267 (1992) 4189-4198
11. Arai M., Scandella D., and Hoyer L.W. Molecular basis of factor VIII inhibition by human antibodies. Antibodies that bind to the factor VIII light chain prevent the interaction of factor VIII with phospholipid. J. Clin. Invest. 83 (1989) 1978-1984
12. Foster P.A., Fulcher C.A., Houghten R.A., and Zimmerman T.S. Synthetic factor VIII peptides with amino acid sequences contained within the C2 domain of factor VIII inhibit factor VIII binding to phosphatidylserine. Blood 75 (1990) 1999-2004
13. Shi J., and Gilbert G.E. Lactadherin inhibits enzyme complexes of blood coagulation by competing for phospholipid-binding sites. Blood 101 (2003) 2628-2636
14. Shi J., Heegaard C.W., Rasmussen J.T., and Gilbert G.E. Lactadherin binds selectively to membranes containing phosphatidyl-l-serine and increased curvature. Biochim. Biophys. Acta 1667 (2004) 82-90
15. Macedo-Ribeiro S., Bode W., Huber R., Quinn-Allen M.A., Kim S.W., Ortel T.L., et al. Crystal structures of the membrane-binding C2 domain of human coagulation factor V. Nature 402 (1999) 434-439
16. Pratt K.P., Shen B.W., Takeshima K., Davie E.W., Fujikawa K., and Stoddard B.L. Structure of the C2 domain of human factor VIII at 1.5 Å resolution. Nature 402 (1999) 439-442
17. Gilbert G.E., Kaufman R.J., Arena A.A., Miao H., and Pipe S.W. Four hydrophobic amino acids of the factor VIII C2 domain are constituents of both the membrane-binding and von Willebrand factor-binding motifs. J. Biol. Chem. 277 (2002) 6374-6381
18. Lewis D.A., Pound M.L., and Ortel T.L. Contributions of Asn2198, Met2199, and Phe2200 in the factor VIII C2 domain to cofactor activity, phospholipid-binding, and von Willebrand factor-binding. Thromb. Haemost. 89 (2003) 795-802
19. Kim S.W., Quinn-Allen M.A., Camp J.T., Macedo-Ribeiro S., Fuentes-Prior P., Bode W., and Kane W.H. Identification of functionally important amino acid residues within the C2-domain of human factor V using alanine-scanning mutagenesis. Biochemistry 39 (2000) 1951-1958
20. Nicolaes G.A., Villoutreix B.O., and Dahlback B. Mutations in a potential phospholipid binding loop in the C2 domain of factor V affecting the assembly of the prothrombinase complex. Blood Coagul. Fibrinolysis 11 (2000) 89-100
21. Peng W., Quinn-Allen M.A., Kim S.W., Alexander K.A., and Kane W.H. Trp2063 and Trp2064 in the factor Va C2 domain are required for high-affinity binding to phospholipid membranes but not for assembly of the prothrombinase complex. Biochemistry 43 (2004) 4385-4393
22. Peng W., Quinn-Allen M.A., and Kane W.H. Mutation of hydrophobic residues in the factor Va C1 and C2 domains blocks membrane-dependent prothrombin activation. J. Thromb. Haemost. 3 (2005) 351-354
23. Kim S.W., Quinn-Allen M.A., Camp J.T., Macedo-Ribeiro S., Fuentes-Prior P., Bode W., and Kane W.H. Identification of functionally important amino acid residues within the C2-domain of human factor V using alanine-scanning mutagenesis. Biochemistry 39 (2000) 1951-1958
24. Mollica L., Fraternali F., and Musco G. Interactions of the C2 domain of human factor V with a model membrane. Proteins: Struct. Funct. Genet. 64 (2006) 363-375
25. Kalafatis M., Rand M.D., and Mann K.G. Factor Va-membrane interaction is mediated by two regions located on the light chain of the cofactor. Biochemistry 33 (1994) 486-493
26. Srivastava A., Quinn-Allen M.A., Kim S.W., Kane W.H., and Lentz B.R. Soluble phosphatidylserine binds to a single identified site in the C2 domain of human factor Va. Biochemistry 40 (2001) 8246-8255
27. Saleh M., Peng W., Quinn-Allen M.A., Macedo-Ribeiro S., Fuentes-Prior P., Bode W., and Kane W.H. The factor V C1 domain is involved in membrane binding: identification of functionally important amino acid residues within the C1 domain of factor V using alanine scanning mutagenesis. Thromb. Haemost. 91 (2004) 16-27
28. Adams T.E., Hockin M.F., Mann K.G., and Everse S.J. The crystal structure of activated protein C-inactivated bovine factor Va: Implications for cofactor function. Proc. Natl Acad. Sci. USA 101 (2004) 8918-8923
29. Stoilova-McPhie S., Villoutreix B.O., Mertens K., Kemball-Cook G., and Holzenburg A. 3-Dimensional structure of membrane-bound coagulation factor VIII: modeling of the factor VIII heterodimer within a 3-dimensional density map derived by electron crystallography. Blood 99 (2002) 1215-1223
30. Stoylova S.S., Lenting P.J., Kemball-Cook G., and Holzenburg A. Electron crystallography of human blood coagulation factor VIII bound to phospholipid monolayers. J. Biol. Chem. 274 (1999) 36573-36578
31. Saenko E.L., Scandella D., Yakhyaev A.V., and Greco N.J. Activation of factor VIII by thrombin increases its affinity for binding to synthetic phospholipid membranes and activated platelets. J. Biol. Chem. 273 (1998) 27918-27926
32. Takeshima K., Smith C., Tait J., and Fujikawa K. The preparation and phospholipid binding property of the C2 domain of human factor VIII. Thromb. Haemost. 89 (2003) 788-794
33. Hsu T.C., Pratt K.P., and Thompson A.R. Factor VIII's C domains bind to platelets. Blood (ASH Ann. Meet. Abstr.) 108 (2006) 1715
34. Gale A.J., Pellequer J.L., Getzoff E.D., and Griffin J.H. Structural basis for hemophilia A caused by mutations in the C domains of blood coagulation factor VIII. Thromb. Haemost. 83 (2000) 78-85
35. Smirnov M.D., and Esmon C.T. Phosphatidylethanolamine incorporation into vesicles selectively enhances factor Va inactivation by activated protein C. J. Biol. Chem. 269 (1994) 816-819
36. Billy D., Willems G.M., Hemker H.C., and Lindhout T. Prothrombin contributes to the assembly of the factor Va-factor Xa complex at phosphatidylserine-containing phospholipid membranes. J. Biol. Chem. 270 (1995) 26883-26889
37. Smeets E.F., Comfurius P., Bevers E.M., and Zwaal R.F. Contribution of different phospholipid classes to the prothrombin converting capacity of sonicated lipid vesicles. Thromb. Res. 81 (1996) 419-426
38. Smirnov M.D., Ford D.A., Esmon C.T., and Esmon N.L. The effect of membrane compositon on the hemostatic balance. Biochemistry 38 (1999) 3591-3598
39. Gilbert G.E., and Arena A.A. Phosphatidylethanolamine induces high affinity binding sites for factor VIII on membranes containing phosphatidyl-l-serine. J. Biol. Chem. 270 (1995) 18500-18505
40. Falls L., Furie B., and Furie B.C. The role of phosphatidylethanolamine in assembly and function of the factor IXa-factor VIIIa complex on membrane surfaces. Biochemistry 39 (2000) 13216-13222
41. Furie B., and Furie B.C. The molecular basis of blood coagulation. Cell 53 (1988) 505-518
42. Huang M., Rigby A.C., Morelli X., Grant M.A., Huang G., Furie B., et al. Structural basis of membrane binding by Gla domains of vitamin K-dependent proteins. Nature Struct. Biol. 10 (2003) 751-756
43. Falls L.A., Furie B.C., Jacobs M., Furie B., and Rigby A.C. The omega-loop region of the human prothrombin gamma-carboxyglutamic acid domain penetrates anionic phospholipid membranes. J. Biol. Chem. 276 (2001) 23895-23902
44. Shi J., Shi Y., Waehrens L.N., Rasmussen J.T., Heegaard C.W., and Gilbert G.E. Lactadherin detects early phosphatidylserine exposure on immortalized leukemia cells undergoing programmed cell death. Cytometry A 69 (2006) 1193-1201
45. Dasgupta S.K., Guchhait P., and Thiagarajan P. Lactadherin binding and phosphatidylserine expression on cell surface-comparison with annexin A5. Transl. Res. 148 (2006) 19-25
46. Pauer H.U., Baird T., Johnston K., Seaton B., Furie B., and Furie B. Prothrombin fragment 1 and annexin V localize differently after laser induced vascular injury in vivo. J. Thromb. Haemost. 3 (2005) OR374
47. Asano K., Miwa M., Miwa K., Hanayama R., Nagase H., Nagata S., and Tanaka M. Masking of phosphatidylserine inhibits apoptotic cell engulfment and induces autoantibody production in mice. J. Exp. Med. 200 (2004) 459-467
48. Otwinowski Z., and Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276 (1997) 307-326
49. Navaza J. AMoRe: an automated package for molecular replacement. Acta Crystallog. sect. A 50 (1994) 157-163
50. Guex N., and Peitsch M.C. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18 (1997) 2714-2723
51. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., et al. Crystallography and NMR system: a new software suite for macromolecular structure determination. Acta Crystallog. sect. D 54 (1998) 905-921
52. Jones T., Zou J., Cowan S., and Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallog. sect. A 47 (1991) 110-119
53. CCP4. The CCP4 suite: programs for protein crystallography. Acta Crystallog. sect. D 50 (1994) 760-763
54. DeLano W.L. The PyMol Molecular Graphics System (2004), DeLano Scientific, San Carlos, CA